In men with coronary artery disease, carriers of the Pro12Ala allele of PPARg have less atherosclerosis, vascular morbidity, and mortality [41]. PPARg also acts as a transrepressor of macrophage inflammatory genes [42]. This evidence concerns the gene PPARG and coronary artery disorder.